الوصف

Future research directions for phytocannabinoids in epilepsy include biomarker-guided therapy, combination strategies with conventional antiepileptics, and investigation of novel minor cannabinoids with anti-seizure potential.

Figure 34

Diagram

Source Paper

Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy.

Pharmaceuticals (Basel, Switzerland) (2020)

PMID: 32751761

DOI: 10.3390/ph13080174

Cite This Figure

![Figure 34: Future research directions for phytocannabinoids in epilepsy include biomarker-guided therapy, combination strategies with conventional antiepileptics, and investigation of novel minor cannabinoids with anti-seizure potential.]()

> Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." *Pharmaceuticals (Basel, Switzerland)*, 2020. PMID: [32751761](https://pubmed.ncbi.nlm.nih.gov/32751761/)

<figure>
  <img src="" alt="Future research directions for phytocannabinoids in epilepsy include biomarker-guided therapy, combination strategies with conventional antiepileptics, and investigation of novel minor cannabinoids with anti-seizure potential." />
  <figcaption>Figure 34. Future research directions for phytocannabinoids in epilepsy include biomarker-guided therapy, combination strategies with conventional antiepileptics, and investigation of novel minor cannabinoids with anti-seizure potential.<br>  Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751761/">32751761</a></figcaption>
</figure>

أدلة ذات صلة

CBD لـ الأرق

التقييم A · 103 دراسات